insights_auto
Why is EDIT up 13.46%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$2.95
arrow_upward
+13.46%(+0.35) 1D
$2.86
arrow_downward
-2.99% (-0.088)bedtimeAfter hours
Closed: Oct 28, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.59
High
$2.96
Low
$2.54
Mkt. cap
453.06M
Avg. vol.
2.91M
Volume
4.43M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
Open
$2.59
High
$2.96
Low
$2.54
Mkt. cap
453.06M
Avg. vol.
2.91M
Volume
4.43M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 After-Hours Movers for Oct. 28, 2026
Yahoo Finance
·
1 hour ago
Semiconductor stocks lose momentum as S&P 500 takes lead
BBN Times
·
13 minutes ago
Nasdaq Composite Rises to 26,549.85 After the Fed Decision as Alphabet Sinks 10% and Microsoft Rises After Hours
Reuters Connect
·
1 day ago
Licensable picture: TUNISIA-ILLUSTRATION-S&P500-STOCK-MARKET
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc